Advances In Anti Cytokine Therapy: Mechanisms Of Action And Efficacy

Advances in Anti Cytokine Therapy: Mechanisms of Action and Efficacy

Advances in Anti-Cytokine Therapy: New Pathways (IL 12/23, IL17, IL23)

ClevelandClinicCME

Understanding the mechanisms of action of new agents: Implications for efficacy and safety

Advances in Anti-Cytokine Therapy for IBD: The Role of IL-12/23 and IL-23 Inhibitors

Efficacy and Safety of Therapeutics in Immuno-modulatory Induced Cytokine Release Syndrome

The Jackson Laboratory

The Science Behind Anakinra - Understanding its Mechanism of Action for Effective Treatment

The Evolving Therapeutic Paradigm in IBD: Optimal Positioning of New and Emerging Agents

Mechanistic model-informed discovery & development of bispecific antibodies for immuno-oncology

Caspase-1 Inhibitor VX-765: Promising Therapy for Inflammatory Diseases | GlpBio

Advances in Rheumatoid Arthritis

ClevelandClinicCME

Webinar - Bispecific Antibodies: The Next Generation of Antibody Therapeutics

GenScript USA Inc.

Understanding and Working With New Immunotherapeutic and Targeted Management Models in Advanced RCC

PeerView Oncology

Engineered T Cells for Cancer

InsideScientific

Cytokine therapy

Bernd Schlereth: Mastering Pharmacokinetics and Immunogenicity of bispecific antibodies

ProImmune thinkpeptides

Cytokine Profiles in Health and Disease

ClevelandClinicCME

Challenges to Precision Medicine for Anti-Cancer Immunotherapy

Yale Cancer Center

Optimizing Biological Therapies in the Modern Era

David Wraith: Antigen-specific tolerance induction: allergy, autoimmunity and anti-drug antibodies

ProImmune thinkpeptides

Recent Advances in Immunotherapy Directing Cells to Address Disease Webinar Leena Gandhi

Beckman Coulter Life Sciences